The analysis of TCGA data revealed a remarkable association between PRR15 downregulation and higher clinical stages, and the corresponding clinical information of the constructed breast cancer tissue chip also displayed lower PRR15 expression in TNBC patients who experienced metastases (Fig. 5a, b). The gene discussed is PRR15; the disease is breast carcinoma.